Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/BBIO
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

BridgeBio Pharma Inc (BBIO) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

BridgeBio Pharma (BBIO) trades at $66.96, up 1.24% with a bearish technical signal despite strong analyst support. The company shows robust revenue growth from $78M in 2022 to $502M in 2025, though it remains unprofitable with a -144.39% net margin. Recent news highlights four global therapy launches planned by 2027, with acoramidis demonstrating positive real-world results in ATTR-CM treatment.
Investment outlook balances high growth potential against significant financial risks. While analyst consensus targets $113.92 (70% upside) with 89% buy ratings, persistent losses and negative equity (-$1.47B) require careful risk assessment. Key catalysts include commercial execution of new launches, while risks center on profitability timeline and competitive pressures.
Read full analysis

Key Stats

  • Market Cap
    $12.99B
  • Volume
    2,064,230
  • Sector
    Health
  • 52W High
    $90.17
  • 52W Low
    $53.24
  • Typical Hold Time
    63 Days
  • Enterprise Value
    $14.77B
  • Div Yield
    -
  • Trading Activity
    0% Sell | 100% Buy
$66.55
52W Low: $53.24
22 Oct 2025
52W High: $90.17
09 Jul 2026

Track BridgeBio Pharma Inc (BBIO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, BridgeBio Pharma Inc has traded between a low of $53.24 and a high of $90.17, highlighting its annual price range. Buy and sell BridgeBio Pharma Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About BridgeBio Pharma Inc

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.

Most Recent News

Content is generated by Aura AI

Aclarion broadens CLARITY trial criteria to speed patient enrollment, keeping trial timeline on track.

Aclarion, Inc. has updated the enrollment criteria for its CLARITY clinical trial to better reflect real-world chronic low back pain patients and accelerate patient recruitment. The revised criteria, approved at most active sites, expand the pool of ...

Market News
38 minutes ago
Aclarion, Inc.
Bullish
news icon
Aclarion broadens CLARITY trial criteria to speed patient enrollment, keeping trial timeline on track.

Zscaler CEO Jay Chaudhry sells 2,852 shares for $550,000

Zscaler CEO Jay Chaudhry has sold 2,852 shares of the company, generating $550,000 from the transaction. This sale could indicate personal financial planning or portfolio rebalancing by the CEO. Investors might watch for any further insider activity ...

Market News
1 hour ago
Anthony Di Pizio
Bearish
news icon
Zscaler CEO Jay Chaudhry sells 2,852 shares for $550,000

Ascentis Independent Advisors adds $1B in assets with four new advisory teams from Raymond James.

Ascentis Independent Advisors has expanded by adding four advisory teams from Raymond James Financial Services, bringing over $1 billion in client assets. These teams, based in California and Colorado, chose Ascentis to access enhanced planning, inve...

Market News
1 hour ago
Not Specified
Bullish
news icon
Ascentis Independent Advisors adds $1B in assets with four new advisory teams from Raymond James.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $12.99B
  • Volume
    2,064,230
  • Sector
    Health
  • 52W High
    $90.17
  • 52W Low
    $53.24
  • Typical Hold Time
    63 Days
  • Enterprise Value
    $14.77B
  • Div Yield
    -
  • Trading Activity
    0% Sell | 100% Buy
$66.55
52W Low: $53.24
22 Oct 2025
52W High: $90.17
09 Jul 2026

Track BridgeBio Pharma Inc (BBIO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, BridgeBio Pharma Inc has traded between a low of $53.24 and a high of $90.17, highlighting its annual price range. Buy and sell BridgeBio Pharma Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!